Chapel Hill, NC, United States of America

Dmitri Kireev

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 5.2

ph-index = 3

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2016-2020

where 'Filed Patents' based on already Granted Patents

9 patents (USPTO):

Title: Innovations in Cancer Treatment: The Contributions of Dmitri Kireev

Introduction

Dmitri Kireev is a notable inventor based in Chapel Hill, North Carolina, recognized for his significant contributions to the field of cancer research and treatment. With a portfolio of nine patents, Kireev is actively engaged in developing innovative therapeutics that target cancer more effectively through novel combinations of compounds.

Latest Patents

Among his latest patents, Kireev has developed pan-TAM inhibitors and Mer/Axl dual inhibitors. These advancements focus on improved therapeutic combinations for treating selected cancers using specific pyrimidine compounds that exert pan-TAM or Mer/Axl dual receptor tyrosine kinase inhibitory activity. The methods also incorporate immune checkpoint inhibitors, such as CTLA4 inhibitors, PD1 inhibitors, and PDL-1 inhibitors, to enhance treatment efficacy. His research also involves pyrrolopyrimidine compounds aimed at cancer therapy, described in compositions formulated for effective treatment strategies.

Career Highlights

Dmitri Kireev is currently affiliated with the University of North Carolina at Chapel Hill, where he contributes to advancing cancer treatment through his research. His dedicated work has not only resulted in multiple patents but also significantly impacted the understanding of therapeutic methods in oncology.

Collaborations

Kireev collaborates closely with fellow researchers Xiaodong Wang and Weihe Zhang. Their partnership fosters a rich academic environment, leading to innovative approaches in cancer research and the development of new therapeutic modalities.

Conclusion

Dmitri Kireev stands out as a visionary inventor whose work is reshaping cancer treatment paradigms. Through his patents and ongoing research at the University of North Carolina at Chapel Hill, Kireev continues to make strides toward improved therapeutic options, significantly benefiting patients in need of innovative cancer treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…